Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events.
Conclusions. During 6 months of treatment, HR increased substantially in CHF patients with SR treated with liraglutide but was not associated with adverse events. The long-term clinical significance of increased HR in liraglutide treated CHF patients needs to be determined.
PMID: 32292074 [PubMed - as supplied by publisher]
Source: Scandinavian Cardiovascular Journal - Category: Cardiology Tags: Scand Cardiovasc J Source Type: research
More News: Arrhythmia | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Electrocardiogram | Endocrinology | Heart | Heart Failure | Laboratory Medicine | PET Scan | Study | Victoza